13S145: ACR/AAHKS Guideline: When to Proceed to THA/TKA and When to Continue Conservative Therapy

Sunday, November 13, 2022

3:00 PM – 3:45 PM Eastern Time

Location: Exhibit Hall A

CE: 0.75

All of the relevant financial relationships listed for faculty have been mitigated.

Moderator(s)

MA

Matthew Austin, MD

Rothman Orthpaedic Institute
Bryn Mawr, PA, United States

Disclosure(s): Corin: Consultant (Ongoing), Royalties (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); DePuy: Consultant (Ongoing), Royalties (Ongoing); Link: Consultant (Ongoing), Royalties (Ongoing); Zimmer Biomet: Royalties (Ongoing)

Describes potential challenges in the delivery of care to patients with osteoarthritis and offers to specify possible solutions. Incorporates new research data to improve the quality of care of patients with degenerative diseases of the knee or hip.

Learning Objectives:

Describe the indications for and efficacy of continuing conservative treatment in patients with moderate to severe osteoarthritis (OA) or osteonecrosis (ON) who developed moderate to severe symptoms or significant loss of function
Identify the indications for total joint replacement in patients with moderate or severe OA or ON who have developed moderate or severe symptoms and/or loss of function
Delineate management of specific medical co-morbidities and the impact on timing of arthroplasty for patients with advanced OA or ON who have significant symptoms

Presentations:

3:00 PM – 3:15 PM Eastern Time

Are We Medically Optimizing Patients with Advanced OA Prior to THA/TKA or Just Delaying Surgery?
Speaker: Susan M. Goodman, MD – Hospital for Special Surgery
3:15 PM – 3:30 PM Eastern Time

In Advanced OA, Is Further Conservative Treatment Such as Bracing or Physical Therapy Effective Before THA/TKA or Just Introducing Delays to Surgery?
Speaker: Jasvinder Singh, MD, MPH – University of Alabama at Birmingham
3:30 PM – 3:45 PM Eastern Time

Q&A